文献速递临床试验与 GCP流行病学与生物统计

基于动机性访谈的干预对比注意对照和常规护理减少卒中后抑郁症状的有效性:多中心随机对照试验(COMMITS)研究方案

The effectiveness of a motivational interviewing-based intervention for reducing depressive symptoms after stroke compared to an attention control and usual care: study protocol for a multi-centre randomised controlled trial (COMMITS).
PubMed 文献 · Trials · 2026-01-28

COMMITS是一项在18家英国医院招募1287例急性卒中患者的多中心随机对照试验,按1:1:1随机分为动机性访谈干预(MIBI)加常规护理组、注意对照(AC)加常规护理组和常规护理(UC)组,主要结局为3个月时患者健康问卷(PHQ-9)自评抑郁。研究旨在区分MIBI的特异性疗效与额外关注带来的非特异性效应,并开展过程评价和经济学评价。

要点

  • 抑郁影响近60%的卒中幸存者,损害康复和生活质量。
  • 一项随机对照试验显示卒中后早期MIBI较单纯常规护理在3个月和12个月时减轻抑郁症状,但无法区分特异性成分与额外关注的作用。
  • 本试验通过三臂设计(MIBI+UC、AC+UC、UC)区分MIBI的特异性疗效与注意效应。

核心结论

  • 研究结果将判断观察到的情绪改善是随时间自然变化、由关注所致,还是可归因于MIBI的治疗性变化。
  • 若MIBI被证实能有效减轻抑郁症状,过程评价将为该干预融入临床护理提供实施依据。

研究设计与样本

  • 多中心随机对照试验,计划在18家英国医院于卒中后28天内招募符合研究入组标准(当前未接受谈话治疗且当前无严重抑郁)的急性卒中患者。
  • 共1287名参与者按1:1:1比例随机分为三组:MIBI+UC组、AC+UC组和UC组。
  • MIBI+UC组和AC+UC组分别额外接受MIBI治疗师或AC提供者的远程(电话/在线)会话,每周4次、每次45分钟,于随机化后6周内开始。
  • 主要结局为随机化后3个月时患者健康问卷(PHQ-9)自评抑郁,并在基线、随机化后6周和3个月收集生活质量等自报指标。
  • 将探索参与者自我效能和信心作为效应机制,以及MIBI剂量和/或治疗联盟对结局的影响。

主要发现

  • 一项随机对照试验显示,卒中后早期给予的谈话治疗MIBI与单纯常规护理相比,在卒中后3个月和12个月时减轻了抑郁症状。
  • 该试验未能明确获益是源于MIBI的特异性成分还是仅源于额外获得的关注。

关键数值与推荐

  • 主要结局为随机化后3个月时的PHQ-9自评抑郁评分。
  • 若MIBI+UC较UC显示获益,将对所有三臂的结局数据拟合混合效应回归模型,并以MIBI+UC为参照组进行适当参数化。
  • 过程评价包括对干预依从性和保真度的定量评估,以及对目的抽样约18名研究参与者和约15名MIBI/AC工作人员的半结构化访谈。
  • 将开展经济学评价探索成本效果。

临床怎么用

  • 若MIBI被证实能有效减轻抑郁症状,过程评价将为该干预融入临床护理提供实施依据。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Depression affects almost 60% of stroke survivors, impacting on recovery and quality-of-life. Depression may be treated with medication or talk-based therapies. One randomised controlled trial showed a talk-based therapy called motivational interviewing-based intervention (MIBI) delivered early after stroke reduced depressive symptoms at 3 and 12 months post-stroke compared with receiving usual care alone. However, it was unclear if the benefit was due to the specific MIBI components or simply the additional attention received. This trial aims to determine the effect of MIBI plus usual care on reducing depressive symptoms post-stroke, relative to usual care (UC), and to an attention control (AC) (social attention without therapeutic content, i.e. general conversation). METHODS: Patients admitted following acute stroke meeting the study eligibility criteria (not currently receiving talk-based therapy and not currently having severe depression) will be recruited across 18 UK hospitals within 28 days of stroke. A total of 1287 participants will be randomised on a 1:1:1 ratio into three groups: MIBI + UC; AC + UC; UC. Participants in MIBI + UC and AC + UC will additionally have remote (telephone/online) sessions with MIBI therapists or AC providers respectively, for four 45-min weekly sessions, beginning within 6 weeks of randomisation. Participant self-report measures of depression (primary outcome, Patient Health Questionnaire (PHQ-9) at 3 months) and quality-of-life will be collected at baseline, 6 weeks and 3 months post-randomisation. The proposed mechanism of effect, via participants' self-efficacy and confidence, and the impact of MIBI dose and/or therapeutic alliance on outcome will also be explored. If benefit of MIBI + UC over UC is demonstrated, mixed effects regression will be fitted to outcome data from all three arms, and appropriate parametrisation with MIBI + UC as the reference group. A mixed-methods process evaluation comprising quantitative assessment of intervention adherence and fidelity and semi-structured interviews with a purposive sample of study participants (n ~ 18) and MIBI/AC staff (n ~ 15) will explore participation, acceptability, and considerations for implementation. An economic evaluation will explore cost-effectiveness. DISCUSSION: The results will inform whether any observed improvements in mood are a natural change over time, due to attention, or a therapeutic change attributable to MIBI. If MIBI is shown to effectively reduce depressive symptoms, the process evaluation will inform implementation of the intervention into clinical care. TRIAL REGISTRATION: ISRCTN, ISRCTN17065351. Registered 01/02/2022, https://www.isrctn.com/ISRCTN17065351 .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Patel K, Watkins C, Benedetto V, et al. The effectiveness of a motivational interviewing-based intervention for reducing depressive symptoms after stroke compared to an attention control and usual care: study protocol for a multi-centre randomised controlled trial (COMMITS). Trials. 2026. PMID: 41593788. doi:10.1186/s13063-026-09429-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。